Home / Recalls / Genentech Inc. / D-0648-2017

D-0648-2017 Class II Terminated

Recalled by Genentech Inc. — South San Francisco, CA

Recall Details

Product Type
Drugs
Report Date
April 12, 2017
Initiation Date
March 13, 2017
Termination Date
May 12, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
748 bottles

Product Description

Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzerland. Distributed by Genentech USA, Inc., South Francisco, CA. 94080, NDC 50242-717-01,UPC 3 50242-717-01.

Reason for Recall

Superpotent Drug: An oversized tablet was found in a bottle.

Distribution Pattern

NJ and IL

Code Information

B1009MC, B1009M9, B1009MA; Exp. 02/18 B1009MT 02/19

Other recalls by Genentech Inc.

  • D-0509-2024 Class II — Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Fran (May 20, 2024)
  • D-0025-2023 Class III — Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing (October 18, 2022)
  • D-0650-2021 Class II — Xolair (omalizumab) Injection, 150 mg/1 mL, 1 prefilled syringe, Rx Only, For Su (June 9, 2021)
  • D-0357-2021 Class III — Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volum (April 20, 2021)
  • D-0416-2018 Class III — Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, (February 5, 2018)
  • D-1175-2017 Class I — Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 (September 5, 2017)
  • D-097-2013 Class III — CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count (September 27, 2012)
  • D-088-2013 Class II — Nutropin AQ NuSpin 10 (somatropin (rDNA origin) injection} 10 mg/ 2mL Genentech, (September 20, 2012)
  • D-087-2013 Class II — Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, (September 20, 2012)
  • D-135-2013 Class I — Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL (July 30, 2012)